Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study

被引：1

作者：

Gavriatopoulou, Maria ^{[1
]}

Vogl, Dan T. ^{[2
]}

Nooka, Ajay ^{[3
]}

Dingli, David ^{[4
]}

Cole, Craig ^{[5
]}

Moreau, Philippe ^{[6
]}

Huff, Carol ^{[7
]}

Yee, Andrew ^{[8
]}

Dimopoulos, Meletios A. ^{[9
]}

Lonial, Sagar ^{[10
]}

Richardson, Paul G. ^{[11
]}

Stewart, Keith ^{[12
]}

Chari, Ajai ^{[13
]}

Richter, Joshua ^{[14
]}

Biran, Noa ^{[14
]}

Siegel, David S. ^{[15
]}

Liu, Jianjun ^{[16
]}

Joshi, Anita ^{[16
]}

Shah, Jatin ^{[16
]}

Shacham, Sharon ^{[16
]}

Kauffman, Michael ^{[16
]}

Jagannath, Sundar ^{[17
]}

机构：

[1] Univ Athens, Sch Med, Athens, Greece

[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[4] Mayo Clin, Rochester, MN USA

[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

[6] CHU Nantes, Univ Hosp Hotel Dieu HME, Nantes, France

[7] Johns Hopkins Univ, Baltimore, MD USA

[8] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[9] Univ Athens, Sch Med, Alexandra Hosp, Athens, Greece

[10] Emory Univ, Atlanta, GA 30322 USA

[11] Harvard Med Sch, Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[12] Mayo Clin, Scottsdale, AZ USA

[13] Mt Sinai Sch Med, New York, NY USA

[14] Hackensack Univ, John Theurer Canc Ctr, Hackensack, NJ USA

[15] Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA

[16] Karyopharm Therapeut Inc, Newton, MA USA

[17] Mt Sinai Hosp, New York, NY 10029 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

Elderly patients; novel agents; relapsed/refractory multiple myeloma;

D O I：

10.1016/j.clml.2019.09.195

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FP-110

引用

页码：E117 / E118

页数：2

共 50 条

[1] Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM Study
Nooka, Ajay K.
Yee, Andrew J.
Huff, Carol Ann
Vogl, Dan T.
Gavriatopoulou, Maria
Chari, Ajai
Moreau, Philippe
Dingli, David
Cole, Craig E.
Lonial, Sagar
Dimopoulos, Meletios A.
Richter, Joshua R.
Vij, Ravi
Tuchman, Sascha A.
Raab, Marc S.
Biran, Noa
Siegel, David S.
Richardson, Paul G.
Liu, Jianjun
Joshi, Anita
Shah, Jatin
Shacham, Sharon
Kauffman, Michael G.
Jagannath, Sundar
BLOOD, 2019, 134
[2] Improvements in Renal Function with Selinexor in Relapsed/Refractory Multiple Myeloma: Post-hoc Analyses from the STORM Study
Vogl, Dan T.
Nooka, Ajay
Gavriatopoulou, Maria
Yee, Andrew
Huff, Carol
Moreau, Philippe
Dingli, David
Cole, Craig
Richardson, Paul G.
Dimopoulos, Meletios A.
Lonial, Sagar
Stewart, Keith
Chari, Ajai
Richter, Joshua
Biran, Noa
Siegel, David S.
Liu, Jianjun
Joshi, Anita
Shah, Jatin
Shacham, Sharon
Kauffman, Michael
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E118 - E119
[3] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
Al-Badriyeh, Daoud
Shafei, Laila
Bashir, Shaima
Abushanab, Dina
Hamad, Anas
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 263 - 263
[4] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
Shafei, Laila
Bashir, Shaima
Chan, Esther W.
Abushanab, Dina
Hamad, Anas
Al-Badriyeh, Daoud
CURRENT PROBLEMS IN CANCER, 2024, 50
[5] EFFICACY AND SAFETY OF SELINEXOR FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS
Abushanab, D.
Mraiche, F.
Al-Badriyeh, D.
VALUE IN HEALTH, 2021, 24 : S22 - S22
[6] Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia
Chen, Christine
Siegel, David
Gutierrez, Martin
Jacoby, Meagan
Hofmeister, Craig C.
Gabrail, Nashat
Baz, Rachid
Mau-Sorensen, Morten
Berdeja, Jesus G.
Savona, Michael
Savoie, Lynn
Trudel, Suzanne
Areethamsirikul, Nuchanan
Unger, T. J.
Rashal, Tami
Hanke, Tim
Kauffman, Michael
Shacham, Sharon
Reece, Donna
BLOOD, 2018, 131 (08) : 855 - 863
[7] Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Schuster, Michael W.
Canales, Miguel A.
Westin, Jason
Zijlstra, Josee M.
Follows, George A.
Karmali, Reem
Kalakonda, Nagesh
Goy, Andre H.
Casasnovas, Rene-Olivier
Vermaat, Joost
Van den Neste, Eric
Choquet, Sylvain
Thieblemont, Catherine
Cavallo, Federica
De La Cruz, Maria de Fatima
Hill, Brian T.
Tilly, Herve
Kassam, Shireen
Bouabdallah, Reda
Jaeger, Ulrich
Gurion, Ronit
Caimi, Paolo
Martin, Peter
Davies, Andrew
Smith, Sonali M.
Collins, Graham P.
Offner, Fritz C.
Salles, Gilles
Ma, Xiwen
Corona, Kelly
Saint-Martin, Jean-Richard
Joshi, Anita A.
Chamoun, Kamal
Wang, Hongwei
Shah, Jatin J.
Shacham, Sharon
Kauffman, Michael G.
Maerevoet, Marie
BLOOD, 2020, 136
[8] Efficacy and safety of elranatamab monotherapy in patients with relapsed/refractory multiple myeloma: a post-hoc subgroup analysis from MagnetisMM-3 with modified eligibility criteria
Raab, Marc
Manier, Salomon
Prince, H. Miles
Nooka, Ajay
Kaedbey, Rayan
Hillengass, Jens
Ishida, Tadao
Sullivan, Sharon
Conte, Umberto
Leip, Eric
Viqueira, Andrea
Raje, Noopur
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S207 - S208
[9] Selinexor for the treatment of patients with relapsed or refractory multiple myeloma
Babar, Anum
Babar, Maham
Zubair, Hina
Shahid, Arzu
Rafique, Sana
Bano, Maimona
Waleed, Madeeha Subhan
Khan, Maimoona
Inayat, Arslan
Safi, Danish
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 535 - 546
[10] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
White, Darrell
LeBlanc, Richard
Venner, Chritopher
Bahlis, Nizar J.
Lentzsch, Suzanne
Gasparetto, Cristina J.
Chen, Christine
Lipe, Brea
Sutherland, Heather
Tuchman, Sascha
Baljevic, Muhamed
Kotb, Rami
Sebag, Michael
Callander, Nancy
Bensinger, William
Kai, Kazuharu
Liu, Jianjun
Sheehan, Heidi
Estepan, Daniel Nova
Shah, Jatin
Schiller, Gary J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55

← 1 2 3 4 5 →